Open access peer-reviewed chapter
Abstract
This chapter presents a comprehensive examination of the Xiangya Lesion, a novel entity resulting from the interaction between the fungus Aspergillus sydowii and human keratinocytes within plantar hyperkeratosis-like lesions. The discovery of these “zombie cells,” formed by integrating the fungus with the host’s cellular machinery, profoundly impacts our understanding of fungal pathogenesis, treatment modalities, and the broader evolutionary strategies of fungi within the human host. The pathogen’s intracellular nature may render traditional antifungal agents ineffective, necessitating the development of novel diagnostic techniques and therapeutic strategies to manage this condition effectively. Through an interdisciplinary exploration of the Xiangya Lesion, this chapter aims to shed light on the complex world of fungal infections and contribute to the ongoing battle between pathogen and host.
Keywords
- Xiangya Lesion
- Aspergillus sydowii
- fungal pathogenesis
- persistence and recurrence of fungal infections
- resistance to antifungal drugs
- intracellular fungal infection
1. Introduction
The fungal world, a realm of astonishing diversity, harbors both beneficial and harmful species. While some fungi play vital roles in ecosystems and human health, others cause devastating diseases [1, 2]. Understanding how fungi interact with their hosts is crucial for developing effective treatments and preventing outbreaks. This chapter explores a groundbreaking discovery that challenges our understanding of fungal pathogenesis: the “Xiangya Lesion.”
Based on research by Zhu et al., the Xiangya Lesion represents a unique manifestation of fungal infection characterized by the formation of “zombie cells”—human keratinocytes hijacked and manipulated by fungal cells [3]. This novel finding, observed in plantar hyperkeratosis-like lesions, suggests a previously unknown complexity in fungal-host interactions. This chapter explores the implications of this discovery, highlighting its potential to shift our understanding of fungal pathogenesis and the development of new therapeutic strategies.
This chapter will address the following:
The discovery and characterization of the Xiangya Lesion.
The unique features of “zombie cells” and their implications for fungal pathogenesis.
The potential of the Xiangya Lesion as a model system for studying fungal-host interactions.
The implications of this discovery for developing new antifungal therapies.
By exploring the Xiangya Lesion, this chapter aims to illuminate the intricate and often surprising ways fungi interact with their hosts, paving the way for a deeper understanding of fungal pathogenesis and the development of more effective treatments.
2. The discovery of zombie cells
The discovery of zombie cells has been revolutionary in medical mycology. These composite entities, resulting from the union of Aspergillus sydowii and human keratinocytes, have challenged long-held paradigms of fungal pathogenesis. This section delves into the intricate details of this discovery, from the initial observations that led to the hypothesis to the rigorous scientific process that confirmed the existence of these enigmatic cells.
The story begins with the persistent puzzle of plantar hyperkeratosis, a condition often attributed to mechanical stress and other noninfectious factors [4, 5]. However, some lesions displayed characteristics that did not align with the conventional understanding of the disease. The meticulous examination of these lesions led to the first hints of an unconventional pathogen at play [6, 7].
Researchers, led by Charles Xiaoxiang Zhu, hypothesized that an unidentified pathogen might contribute to forming hyperkeratotic lesions [3]. This hypothesis stemmed from the observation that these lesions often coincided with fungal infections, were notoriously difficult to cure, and had high relapse rates. The team investigated this possibility using histological examinations, cell culture techniques, and genetic sequencing.
The serendipitous discovery of zombie cells emerged from a meticulous investigation into plantar hyperkeratosis-like lesions (Figures 1 and 2). These lesions, typically appearing as thickened skin on the soles of the feet, were found to harbor more than just the usual suspects of fungal infections. Groundbreaking research led by Charles Xiaoxiang Zhu unveiled a novel phenomenon: Aspergillus sydowii forming composite cells with human keratinocytes, termed “zombie cells.” [3].
Figure 1.
Xiangya Lesions on right foot. A: A Xiangya Lesion manifested as a plantar callus, measuring 28 × 30 mm2 (A1). After partial trimming, the lesion was treated with 100 mg of aspirin powder to soften the hyperkeratotic tissue, resulting in a white appearance, and with 100 mg of terbinafine or itraconazole powder to inhibit fungal growth, which led to pigmented dark gray and brown colors. B: A hyperkeratotic growth on the small toe, with B2 showing fungal growth on the lesion during humid, rainy weather in early autumn. C1: Softened Xiangya Lesions on the toes resembling tinea pedis in rainy weather. C2: Dermatitis-like Xiangya Lesion on the dorsal aspect of the toes and onychomycosis-like nail Xiangya Lesions.
Figure 2.
Discovery of intracellular fungal infection of skin keratinocytes. Panel I (Xiangya Lesion culture in human cell culture media): A) Hyperkeratotic tissue was trimmed from the plantar lesion and divided into two pieces. B) The tissue pieces were placed in the wells of a 6-well culture plate with 2.5 ml of ATG293 medium and incubated at 37°C for 5 days. Multiple molds were observed in culture B1, while budding growth for the tissue was seen in culture B2, as indicated by the white arrows. C) After five additional weeks of incubation at 37°C, a tumor-like mass measuring 9 × 8 × 7.5 mm3 grew out from the lesion tissue. D, F) The tumor-like tissue was broken up, and the pieces were further incubated in a fresh culture medium. E, G) The non-tumor portion of the lesion tissue was also incubated with fresh medium, and after 5 days. Panel II (microscopic photos corresponding to Panel I): T) Fungus photographed in a liquid culture, corresponding to Figure B1. U, V) The fresh tumor-like tissue from Figure D was examined directly under a microscope or after staining with trypan blue for 15 minutes, revealing that the tumor was composed of keratinocytes of variable sizes, approximately 20–40 μm in length. W, X) Microscopic photos corresponding to the culture of Figure F, in which the tumor-like tissue resulted in the disappearance of the tumor cells and the replacement by fungal balls. Y, Z) The culture of Figure G was stained with trypan blue and examined under a microscope, showing fungal hyphae growing and breaking out from the epithelial cells.
Figure 3.
Immunohistochemical findings. A, B: Microscopic images of consecutive tissue sections of the hyperkeratotic lesion on the right fifth toe with positive immunohistochemical staining using anti-epithelial membrane antigen (EMA) antibodies (A) and anti-
Figure 4.
Electronic microscopic examinations of Xiangya Lesions. TEM images from biopsies of the right plantar (A) and fifth toe (B) hyperkeratotic lesions showed stratum spinosum cells, some of which were irregular shapes and sizes. All cells lacked human nuclei, and some cellular membranes had filament-filled cytoplasmic spines and desmosome structures. Many inclusion bodies approximately 0.4–0.7 um in diameter was observed in the cytoplasm of the cells, surrounded by abundant rough endoplasmic reticulum (RER) and polyribosomes, some of which exhibited active divisions. A1 and B1: Irregular epithelial cells of the right foot plantar callus-like lesion and the right small toe hyperkeratotic lesion, respectively. A2 and B2: Focal magnifications of A1 and B1, respectively, to observe the subcellular structures and fungal nuclei.
3. Formation mechanisms of composite cells: a detailed exploration
The development of composite cells, or “zombie cells,” within plantar hyperkeratosis-like lesions presents a biological enigma that challenges our understanding of cellular biology and pathogenesis. This section delves into the potential formation mechanisms of these unique entities, considering the biological processes that may lead to the fusion of fungal and human cells.
3.1 Initial infection and internalization
The formation of composite cells is believed to begin with Aspergillus sydowii entering the host tissue, potentially through microlesions or natural skin openings like hair follicles and sweat glands. The fungus may secrete enzymes that degrade the extracellular matrix, facilitating its penetration into the epidermis [8].
3.2 Intracellular survival and evasion of host defenses
Once internalized, Aspergillus sydowii must evade the host’s immune response to survive intracellularly. The fungus is theorized to manipulate the host cell’s machinery, possibly by suppressing apoptosis, modulating signaling pathways, or exploiting the host’s nutrient supply to create a survival-conducive niche [9, 10].
3.3 Formation of anucleated epithelial cells and integration of fungal elements
Observations of anucleated epithelial cells within hyperkeratotic lesions suggest a process where the host cell’s nucleus is either expelled or degraded, creating a cellular structure suitable for fungal integration. The subsequent integration of fungal elements with these cells may involve endocytosis-like mechanisms, leading to the formation of composite cells [11].
3.4 Development of nucleus-like bodies and proliferation
The composite cells exhibit nucleus-like bodies that stain positively for fungal proteins, indicating a form of modified fungal nuclei within the host cell. These cells can proliferate, contributing to lesion overgrowth (Figure 2), potentially due to the interference of fungal components with the host cell’s growth regulatory mechanisms [12].
3.5 Transformation, disease recurrence, and pathogenesis implications
Environmental or cellular changes may trigger the composite cells’ ability to revert to natural fungal forms, leading to tissue destruction and infection spread, which may explain disease recurrence. This capacity has significant implications for fungal pathogenesis, offering an explanation for the chronicity and treatment resistance observed in plantar hyperkeratosis [13].
3.6 Future research directions and conclusion
Elucidating the molecular interactions during composite cell formation is vital for developing therapeutic strategies. Future research should identify the factors and pathways involved in this process and determine the genetic changes within the host cell. The formation of composite cells in plantar hyperkeratosis-like lesions is a complex interaction between the human host and the fungal pathogen, and further research is essential for advancing our understanding and treatment of these infections [14].
4. Implications for fungal pathogenesis
The identification of composite cells, or “zombie cells,” within plantar hyperkeratosis-like lesions has profound implications for our understanding of fungal pathogenesis. This novel form of fungal infection may significantly alter our approach to diagnosing, treating, and preventing fungal diseases.
4.1 Redefining fungal-host interactions
The traditional view of fungal infections involves the invasion of host tissues by extracellular fungal elements, which are then targeted by the immune system and medical interventions [15]. However, the existence of zombie cells suggests a more nuanced interaction where the fungus and host cells merge. This allows the pathogen to potentially evade immune detection and therapeutic efforts [3].
4.2 Challenges in detection and diagnosis
The ability of
4.3 Resistance to antifungal therapies
The formation of composite cells may contribute to the resistance of certain fungal infections to antifungal treatments. Many antifungal drugs target the fungal cell wall or membrane, which may be ineffective if the fungus is shielded within the host cell [16]. This resistance mechanism could explain the high relapse rates and difficulty in curing some fungal infections [17].
4.4 Evolutionary adaptations of fungi
The formation of composite cells could represent an evolutionary adaptation that allows fungi to survive in a hostile host environment. By integrating with host cells, fungi may gain access to nutrients and a protective niche while avoiding immune surveillance. Understanding this adaptation can provide insights into the evolutionary pressures that drive pathogenicity in fungi [18, 19, 20].
4.5 Impact on host immune response
The presence of composite cells may alter the host’s immune response to fungal infections. The immune system may recognize the composite cells as foreign, leading to inflammation and tissue damage. Conversely, it may be deceived into tolerating the fungal presence, allowing the infection to persist [21, 22].
4.6 Role in chronic infections and recurrences
The formation of composite cells may play a critical role in the chronicity of certain fungal infections and their tendency to recur. These cells can transform back into infectious fungal forms, which could be a key factor in the relapse of symptoms after treatment. Understanding this transformation process could reveal new targets for preventing recurrence [23, 24].
4.7 Broader implications for mycology
The discovery of zombie cells has broader implications for mycology. It raises questions about the prevalence of similar composite cells in other fungal infections and suggests that fungi may have a greater capacity for intracellular survival than previously recognized. This could lead to a reevaluation of existing fungal disease models and the development of new research directions [25].
4.8 Development of novel therapeutic strategies
The implications of composite cell formation for fungal pathogenesis necessitate developing novel therapeutic strategies. These may include drugs that can penetrate host cells to target intracellular fungi, immunomodulatory therapies that enhance the host’s ability to clear infected cells and genetic approaches that disrupt the formation or function of composite cells [26, 27].
4.9 Potential for host-directed therapies
In addition to directly targeting the fungus, understanding composite cell formation may lead to host-directed therapies. These therapies could involve modulating the host’s cellular processes to prevent integrating fungal elements, enhancing the host’s ability to recognize and eliminate infected cells, or altering the host environment to make it less conducive to fungal survival [28].
The formation of composite cells in fungal infections represents a significant shift in our understanding of fungal pathogenesis. It challenges existing paradigms and demands a reevaluation of diagnostic and therapeutic approaches. As research continues to unravel the complexities of these interactions, it is poised to transform how we study, diagnose, and treat fungal diseases [29].
5. Evolutionary considerations
The discovery of composite cells, particularly those involving
5.1 Evolutionary pressures leading to intracellular survival
The evolution of pathogenic fungi involves a continuous arms race with their hosts, where both parties are under selective pressure to develop new survival strategies. The ability of certain fungi to survive and even thrive within host cells may have evolved in response to the host’s immune defenses and antifungal treatments. This adaptation allows the fungus to persist in an environment where extracellular counterparts would be quickly eliminated [30].
5.2 The concept of parasitism and symbiosis in fungi
The formation of composite cells blurs the line between parasitism and symbiosis. While parasitism typically harms the host, the symbiotic relationship seen in composite cells suggests a level of cooperation or tolerance. This could indicate an evolutionary path where the fungus and host cell have reached a delicate balance, allowing the fungus to utilize the host’s resources without immediately causing harm [31].
5.3 The role of genetic drift and selection in fungal pathogenesis
Genetic drift and natural selection play significant roles in the evolution of fungal pathogenesis. The emergence of composite cells may result from random genetic mutations that conferred a survival advantage within host tissues. Over time, these advantageous traits would be selected, leading to the prevalence of strains capable of forming composite cells within a population [32].
5.4 Co-evolution with the host immune system
The host immune system is a major driving force in the evolution of fungal pathogens. The ability of
5.5 The evolutionary trade-offs of intracellular lifestyle
The intracellular lifestyle of the fungus within composite cells may involve trade-offs. While offering protection from the host’s immune system, it may also limit the fungus’s ability to reproduce and spread. The evolution of mechanisms that allow the fungus to transition between intracellular and extracellular states could be a key factor in this strategy’s success [34, 35].
5.6 Horizontal gene transfer and the acquisition of novel traits
Horizontal gene transfer (HGT) could play a role in evolving pathogenic traits in fungi. The ability to form composite cells may have been acquired through HGT from other intracellular pathogens, allowing
5.7 The impact of environmental factors on fungal evolution
Environmental factors, including changes in temperature, humidity, and nutrient availability, can influence the evolution of fungal pathogens. The adaptation to form composite cells may have been favored in environments where the host’s immune defenses are robust, leading to the selection of fungal strains that can survive intracellularly [38, 39].
5.8 The evolution of virulence factors
The evolution of virulence factors in fungi is complex, involving the pathogen’s ability to cause disease and evade host defenses. The formation of composite cells may represent a novel virulence factor that has evolved to enhance the pathogen’s survival within the host [40].
5.9 Speciation and the role of composite cells in fungal diversity
The ability to form composite cells could influence the speciation of fungi. Different strains or species of
5.10 Future directions in evolutionary research
Future research should aim to uncover the evolutionary history of the ability to form composite cells. This could involve comparative genomic studies to identify genes associated with this trait, phylogenetic analyses to trace the emergence of this capability, and experimental evolution studies to understand the selective pressures that favor its development [43].
The formation of composite cells by
6. Pathogenesis and clinical manifestations of the Xiangya Lesion
The Xiangya Lesion, characterized by composite cells formed by
6.1 Pathogenesis of the Xiangya Lesion
The pathogenesis of the Xiangya Lesion is multifaceted, involving several steps that culminate in hyperkeratotic lesions.
6.1.1 Colonization and penetration
The process begins with
6.1.2 Invasion and integration
6.1.3 Proliferation and overgrowth
The composite cells contribute to the Xiangya Lesion’s pathogenesis through uncontrolled proliferation and overgrowth [3]. This abnormal cellular growth results in skin thickening, leading to the characteristic hyperkeratotic lesions. The overgrowth may be driven by fungal components within the composite cells, disrupting normal cell cycle regulation.
6.1.4 Immune evasion and persistence
A key pathogenic feature of the Xiangya Lesion is the composite cells’ ability to evade the host’s immune response [3]. The fungal elements are effectively shielded within the host cells, making them less susceptible to immune recognition and clearance. This immune evasion significantly contributes to the lesions’ persistence and recurrence.
6.2 Clinical manifestations
6.2.1 Hyperkeratotic lesions
The primary clinical manifestation of the Xiangya Lesion is the presence of hyperkeratotic lesions on the plantar regions of the feet [3]. These lesions are often thick, hard, and may be accompanied by fissuring or cracking.
6.2.2 Patient discomfort
Patients may report discomfort, pain, and a feeling of heavy or stiff skin in the affected areas.
6.3 Diagnostic challenges
6.3.1 Atypical presentation
Diagnosing the Xiangya Lesion can be challenging due to its atypical presentation and the difficulty in detecting fungal elements within the composite cells.
6.3.2 Limitations of traditional methods
Traditional fungal culture methods may fail to isolate the pathogen if it is primarily intracellular.
6.4 Treatment considerations
6.4.1 Unique pathogenesis
Treatment of the Xiangya Lesion must consider the condition’s unique pathogenesis.
6.4.2 Limited efficacy of standard treatments
Standard antifungal treatments may be less effective due to the pathogen’s intracellular nature.
6.4.3 Combination therapies
Combination therapies targeting both the fungal and host cell components of the composite cells may be necessary.
6.4.4 Future directions
Treatments aimed at modulating the host’s immune response or disrupting the formation of composite cells are areas of active investigation.
6.5 Clinical challenges
6.5.1 Recurrence and chronicity
The recurrence and chronicity of the Xiangya Lesion are significant clinical concerns. The fungus’s ability to persist within host cells and the difficulty in completely eradicating the infection contributes to high relapse rates. Long-term management strategies and prophylactic measures are essential to reduce the risk of recurrence.
6.5.2 Impact on patient quality of life
The Xiangya Lesion can significantly impact a patient’s quality of life [3]. The physical discomfort and cosmetic appearance of the lesions can lead to reduced mobility, social stigma, and psychological distress. Addressing these factors as part of a comprehensive treatment plan is crucial.
6.6 Future directions in research and treatment
6.6.1 Molecular mechanisms
Future research into the Xiangya Lesion should focus on elucidating the molecular mechanisms underlying the formation of composite cells and the pathogenesis of the lesions.
6.6.2 Targeted therapies and prevention
This knowledge can inform the development of targeted therapies and preventive strategies.
6.6.3 Epidemiology
Research into the epidemiology of the Xiangya Lesion can help identify risk factors and improve our understanding of its prevalence and distribution.
Conclusion: The Xiangya Lesion, with its complex pathogenesis and clinical manifestations, represents a significant challenge in dermatology and mycology. Understanding the intricate interplay between the host and the pathogen is key to developing effective diagnostic, treatment, and prevention strategies. As our knowledge of this condition grows, so too will our ability to manage and ultimately cure these challenging lesions.
7. Clinical and therapeutic implications
The Xiangya Lesion’s clinical presentation often mimics other dermatological conditions, complicating diagnosis and necessitating a reevaluation of current diagnostic and treatment protocols for fungal infections. This section explores the challenges faced in clinical practice and proposes potential therapeutic strategies that may be effective against the Xiangya Lesion’s unique pathogenesis.
7.1 Clinical presentation and diagnosis
7.1.1 Mimicking other conditions
Patients with the Xiangya Lesion typically exhibit plantar hyperkeratosis, which can be mistaken for common calluses or other noninfectious skin conditions.
7.1.2 High index of suspicion
Accurate diagnosis requires a high index of suspicion.
7.1.3 Advanced diagnostic techniques
Diagnosis may involve advanced diagnostic techniques such as skin biopsies, histological examination, and molecular identification of the fungal pathogen.
7.2 Diagnostic challenges and solutions
7.2.1 Intracellular nature of the pathogen
The intracellular nature of
7.2.2 Molecular diagnostics
The use of molecular diagnostic methods, such as PCR, can detect the presence of fungal DNA within the composite cells, offering a more sensitive and specific diagnostic approach.
7.3 Antifungal resistance and treatment failures
7.3.1 Resistance to conventional treatments
The resistance of the Xiangya Lesion to conventional antifungal treatments is a major clinical concern. The intracellular location of the fungus may shield it from antifungal drugs that typically target extracellular fungal elements.
7.3.2 Understanding resistance mechanisms
Understanding the mechanisms of resistance is crucial for developing new therapeutic strategies.
7.4 Potential therapeutic approaches
7.4.1 Novel drug development
Given the unique pathogenesis of the Xiangya Lesion, novel therapeutic approaches are necessary. This may involve developing drugs that can penetrate host cells and target intracellular fungi.
7.4.2 Immunomodulation
Therapies that modulate the host’s immune response to better recognize and eliminate the composite cells could be beneficial.
7.5 Specific therapeutic strategies
7.5.1 Immunomodulatory therapies
Immunomodulatory therapies that enhance the host’s immune response against the fungal pathogen maybe a promising avenue for treatment. This could involve using cytokines, immune-stimulating complexes, or other agents that boost the host’s ability to clear the infection.
7.5.2 Combination therapies
Combination therapies targeting both the fungal and host components of the composite cells may be more effective than single-agent treatment]. This could involve combining antifungal drugs with different mechanisms of action and agents that disrupt the host-fungus interaction.
7.5.3 Host-directed therapies
Host-directed therapies aim to alter the host environment to make it less conducive to fungal survival and proliferation [39]. This could involve treatments that inhibit the formation of composite cells or promote the host’s natural cell turnover to remove infected cells.
7.5.4 Surgical interventions
In some cases, surgical interventions may be necessary to manage Xiangya Lesion, particularly when conservative treatments have failed [40]. Surgical options could include debridement of the affected tissue or more extensive procedures to remove larger areas of infected skin.
7.6 Patient management and public health
7.6.1 Patient education and compliance
Educating patients about the nature of the Xiangya Lesion, its treatment, and the importance of compliance with therapy is critical. Given the chronic and relapsing nature of the condition, patients must understand the long-term management and the need for ongoing monitoring and care.
7.6.2 Preventive measures
Preventive measures are essential to reduce the risk of developing the Xiangya Lesion. This could involve maintaining good foot hygiene, wearing appropriate footwear, and avoiding environments that may predispose to fungal infections.
7.6.3 Future research directions
Future research should focus on understanding the molecular and cellular mechanisms underlying the formation and persistence of the Xiangya Lesion. This knowledge can inform the development of targeted therapies and preventive strategies. Additionally, research into the epidemiology and risk factors for the Xiangya Lesion can help identify those most at risk and guide public health initiatives.
Conclusion: The clinical and therapeutic implications of the Xiangya Lesion are complex and require a multifaceted approach to management. As our understanding of this condition grows, so too will our ability to develop effective treatments and improve patient outcomes. It is through continued research and innovation that we will ultimately overcome the challenges posed by this intriguing and clinically significant fungal pathogenesis.
8. Future research directions
The discovery of the Xiangya Lesion and the unique pathogenesis of
8.1 Molecular mechanisms of infection
A detailed understanding of how
Identifying the fungal and host factors involved in forming composite cells.
Investigating the role of fungal effector proteins and host cell receptors in this process [49].
8.2 Immunological response to infection
The host’s immunological response to the Xiangya Lesion is a key area for future research. Studies should investigate:
How the host’s immune system recognizes and responds to the infection.
How the fungus evades or manipulates these defenses.
The potential for developing immunotherapies that enhance the host’s ability to clear the infection [50].
8.3 Genetic and epigenetic factors
Research into the genetic and epigenetic factors influencing susceptibility to and progression of the Xiangya Lesion is essential. This may include studying:
Genetic variations among individuals that affect their response to the infection.
Epigenetic changes within host cells due to fungal integration.
8.4 Evolutionary biology of aspergillus sydowii
The evolutionary biology of
Comparative genomics and phylogenetic analyses can provide insights into the evolutionary pressures that led to this adaptation and its prevalence among other fungal species [51].
8.5 Development of new diagnostic tools
Developing new diagnostic tools for accurate and efficient Xiangya Lesion detection is critical. This may involve:
Creating new molecular assays, imaging techniques, or biomarkers specific to the infection [52].
8.6 Novel antifungal agents
Given the resistance of the Xiangya Lesion to conventional antifungal treatments, developing new antifungal agents is imperative. These should:
Target the unique aspects of the infection, such as the fungal components within composite cells.
Disrupt the mechanisms allowing the fungus to proliferate within the host [53].
8.7 Host-directed therapies
Research into host-directed therapies that alter the host environment to hinder fungal survival is another promising avenue. This may include treatments that:
Inhibit the formation of composite cells.
Enhance the host’s natural cell turnover to eliminate infected cells.
8.8 Immunomodulatory approaches
Immunomodulatory approaches that enhance the host’s immune response to the infection are a significant area for future research. This may involve using:
Cytokines, toll-like receptor agonists, or other immune-stimulating agents that boost the host’s ability to recognize and clear infected cells [54].
8.9 Impact of environmental factors
The impact of environmental factors on the development and progression of the Xiangya Lesion should be investigated. This can include studying the role of:
8.10 Clinical trials and treatment protocols
Clinical trials to evaluate the efficacy and safety of new treatments for the Xiangya Lesion are essential. This should involve:
Developing standardized treatment protocols and outcome measures to assess the success of these therapies.
8.11 Epidemiological studies
Epidemiological studies are needed to determine:
The prevalence, risk factors, and geographic distribution of the Xiangya Lesion.
This information can inform public health strategies and guide resource allocation for prevention and treatment [54].
8.12 Education and awareness
Increasing awareness about the Xiangya Lesion among healthcare professionals and the general public is critical. Educational initiatives should focus on:
The signs, symptoms, and transmission of the infection.
The importance of early diagnosis and treatment.
Early diagnosis and treatment of Aspergillus infection may prevent Xiangya Lesion formation.
8.13 Interdisciplinary collaboration
Future research should encourage interdisciplinary collaboration between:
Dermatologists, mycologists, immunologists, geneticists, and other relevant fields.
This collaborative approach can lead to a more comprehensive understanding of Xiangya Lesion and the development of more effective treatment strategies.
Conclusion: The Xiangya Lesion represents a significant challenge in medical mycology and dermatology. Future research should build on the current understanding of this condition, focusing on molecular mechanisms, immunological responses, genetic factors, and developing novel diagnostic and therapeutic tools. Through continued research and collaboration, significant strides can be made in managing and ultimately curing this complex fungal infection.
9. Conclusion
The exploration of the Xiangya Lesion and its implications for fungal pathogenesis has revealed a complex and intriguing landscape of host-fungus interactions.
9.1 Synergistic pathogenesis
The Xiangya Lesion’s pathogenesis is a synergistic process where the fungus and host cell coalesce into the “zombie cell.” This phenomenon challenges traditional pathogenesis models and suggests a more nuanced view of host-pathogen interactions, blurring the line between self and nonself.
9.2 Diagnostic innovations
The diagnostic challenges presented by the Xiangya Lesion necessitate developing innovative diagnostic tools. Molecular techniques like PCR and DNA sequencing have proven invaluable in identifying the fungal presence within composite cells. Future research may uncover additional biomarkers or imaging techniques to detect these unique cells specifically.
9.3 Therapeutic advances
The Xiangya Lesion’s resistance to conventional antifungal therapies has spurred the search for new treatment modalities. This includes developing drugs that target intracellular pathogens, immunomodulatory therapies to enhance the host’s immune response and host-directed therapies that disrupt the formation of composite cells.
9.4 Evolutionary insights
The evolutionary considerations of the Xiangya Lesion provide a framework for understanding how
9.5 Clinical management
Managing the Xiangya Lesion clinically requires a multidisciplinary approach involving dermatologists, mycologists, immunologists, and other specialists. Developing standardized treatment protocols and patient education initiatives will be critical in improving patient outcomes.
9.6 Public health implications
The public health implications of the Xiangya Lesion extend beyond individual patient care. Understanding the epidemiology of this condition – its prevalence, risk factors, and geographic distribution – is essential for informing public health strategies for prevention and control.
9.7 Research priorities
Future research priorities should include:
A deeper investigation into the molecular dialog between
Aspergillus sydowii and human keratinocytes.* Developing new diagnostic and therapeutic tools.
* Implementing clinical trials to evaluate the efficacy of these innovations.
9.8 Interdisciplinary collaboration
The complexity of the Xiangya Lesion demands an interdisciplinary approach to research and clinical practice. Collaboration between biologists, clinicians, and public health professionals will be key to advancing our understanding of this condition and improving patient care.
9.9 Knowledge dissemination
Disseminating knowledge about the Xiangya Lesion to the scientific community and the general public is critical. This includes publishing research findings in peer-reviewed journals, presenting at scientific conferences, and engaging in public education campaigns.
9.10 Ethical considerations
Ethical considerations in research and patient care are paramount, particularly when considering novel diagnostic and therapeutic techniques.
Ensuring research is conducted ethically and patients are fully informed about their treatment options is essential.
9.11 Long-term vision
The long-term vision for Xiangya Lesion research is to develop a comprehensive understanding of this condition, from its molecular underpinnings to its clinical manifestations. This knowledge will inform the development of effective treatments and, ultimately, the prevention of the disease.
In conclusion, the Xiangya Lesion represents a significant advancement in our understanding of fungal pathogenesis. The research presented here has broad implications for medical mycology and the potential to transform how we diagnose and treat fungal infections. As we continue to unravel the complexities of this condition, we move closer to a future where the challenges posed by the Xiangya Lesion are effectively managed and, hopefully, eradicated.
Acknowledgments
The author acknowledges the use of Claude 3 for language polishing of the manuscript.
Conflict of interest
The authors declare no conflict of interest.
References
- 1.
Heilmann-Clausen J, Barron E, Boddy L, Dahlberg A, Griffith G, Nordén J, et al. A fungal perspective on conservation biology. Conservation Biology. 2015; 29 :61-68. DOI: 10.1111/cobi.12388 - 2.
Yakop F, Taha H, Shivanand P. Isolation of fungi from various habitats and their possible bioremediation. Current Science. 2019; 116 (5):733-740. DOI: 10.18520/cs/v116/i5/733-740 - 3.
Zhu C, Li X, Tan X, Wu G. Zombie cells, composite cells of fungal–human keratinocytes of plantar hyperkeratosis-like lesions. Mycopathologia. 2019; 184 :597-605. DOI: 10.1007/s11046-019-00369-0 - 4.
Spink M, Menz H, Lord S. Distribution and correlates of plantar hyperkeratotic lesions in older people. Journal of Foot and Ankle Research. 2009; 2 :8-8. DOI: 10.1186/1757-1146-2-8 - 5.
Freeman DB. Corns and calluses resulting from mechanical hyperkeratosis. American Family Physician. 2002; 65 (11):2277-2280 - 6.
Pereiro et al. Plantar hyperkeratosis due to Fusarium verticillioides in a patient with malignancy. Clinical and Experimental Dermatology. 1999; 24 :175-178. DOI: 10.1046/j.1365-2230.1999.00447.x - 7.
Rothman S et al. Systemic disturbances in recalcitrant trichophyton rubrum (purpureum) infections; studies and short report on therapeutic experiments. A.M.A. Archives of Dermatology and Syphilology. 1953; 67 (3):239-246. DOI: 10.1001/ARCHDERM.1953.01540030002001 - 8.
Scorzoni L, Silva A, Marcos C, Assato P, Melo W, Oliveira H, et al. Antifungal therapy: New advances in the understanding and treatment of mycosis. Frontiers in Microbiology. 2017; 8 :36. DOI: 10.3389/fmicb.2017.00036 - 9.
Hopsu-Havu V, Sonck C, Tunnela E. Production of elastase by pathogenic and non-pathogenic fungi. Mycoses. 1972; 15 :105-110. DOI: 10.1111/j.1439-0507.1972.tb01357.x - 10.
Cooney N, Klein B. Fungal adaptation to the mammalian host: It is a new world, after all. Current Opinion in Microbiology. 2008; 11 (6):511-516. DOI: 10.1016/j.mib.2008.09.018 - 11.
Cornejo E, Schlaermann P, Mukherjee S. How to rewire the host cell: A home improvement guide for intracellular bacteria. The Journal of Cell Biology. 2017; 216 :3931-3948. DOI: 10.1083/jcb.201701095 - 12.
Arunachalam D, Namperumalsamy V, Prajna L, Kuppamuthu D. Human corneal epithelial cells internalize aspergillus flavus spores by actin-mediated endocytosis. Infection and Immunity. 2021; 89 (6):e00794-e00820. DOI: 10.1128/IAI.00794-20 - 13.
Pandey A, Ding S, Qin Q , Gupta R, Gomez G, Lin F, et al. Global reprogramming of host kinase Signaling in response to fungal infection. Cell Host & Microbe. 2017; 21 (5):637-649.e6. DOI: 10.1016/j.chom.2017.04.008 - 14.
Zhu CX. Season, weather, arthritis, dermatitis and cardiovascular abnormalities—a case of systemic diseases caused by fungal foot infection and its secreted proteins. 2018. DOI: 10.13140/rg.2.2.11508.60807. Available from: https://www.researchgate.net/publication/329906487 . [Accessed: January 18, 2019] - 15.
Souza J, Gurgel I, Malacco N, Martins F, Queiroz-Junior C, Teixeira M, et al. Pre-exposure with extracellular vesicles from aspergillus fumigatus attenuates inflammatory response and enhances fungal clearance in a murine model pulmonary Aspergillosis. Frontiers in Cellular and Infection Microbiology. 2022; 12 :898619. DOI: 10.3389/fcimb.2022.898619 - 16.
Lima S, Colombo A, Júnior J. Fungal Cell Wall: Emerging antifungals and drug resistance. Frontiers in Microbiology. 2019; 10 :2573. DOI: 10.3389/fmicb.2019.02573 - 17.
Hasim S, Coleman J. Targeting the fungal cell wall: Current therapies and implications for development of alternative antifungal agents. Future Medicinal Chemistry. 2019; 11 (8):869-883. DOI: 10.4155/fmc-2018-0465 - 18.
Hernández-Chávez M, Pérez-García L, Niño-Vega G, Mora-Montes H. Fungal strategies to evade the host immune recognition. Journal of Fungi. 2017; 3 :51. DOI: 10.3390/jof3040051 - 19.
Crawford A, Wilson D. Essential metals at the host–pathogen interface: Nutritional immunity and micronutrient assimilation by human fungal pathogens. FEMS Yeast Research. 2015; 15 (7):fov071. DOI: 10.1093/femsyr/fov071 - 20.
Erwig L, Gow N. Interactions of fungal pathogens with phagocytes. Nature Reviews Microbiology. 2016; 14 :163-176. DOI: 10.1038/nrmicro.2015.21 - 21.
Romani L. The T cell response against fungal infections. Current Opinion in Immunology. 1997; 9 (4):484-490. DOI: 10.1016/S0952-7915(97)80099-4 - 22.
García-Carnero L, Martínez-Álvarez J, Salazar-García L, Lozoya-Pérez N, González-Hernández S, Tamez-Castrellón A. Recognition of fungal components by the host immune system. Current Protein & Peptide Science. 2019; 21 (3):245-264. DOI: 10.2174/138920372 1666191231105546 - 23.
Hopke A, Brown A, Hall R, Wheeler R. Dynamic fungal Cell Wall architecture in stress adaptation and immune evasion. Trends in Microbiology. 2018; 26 (4):284-295. DOI: 10.1016/j.tim.2018.01.007 - 24.
Cohen M, Istùriz R, Malech H, Root R, Wilfert C, Gutman L, et al. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. The American Journal of Medicine. 1981; 71 (1):59-66. DOI: 10.1016/0002-9343(81)90259-X - 25.
Wuyts J, Dijck P, Holtappels M. Fungal persister cells: The basis for recalcitrant infections? PLoS Pathogens. 2018; 14 (10):e1007301. DOI: 10.1371/journal.ppat.1007301 - 26.
Min K, Neiman A, Konopka J. Fungal pathogens: Shape-shifting invaders. Trends in Microbiology. 2020(11):922-933. DOI: 10.1016/j.tim.2020.05.001 - 27.
Casadevall A. Evolution of intracellular pathogens. Annual Review of Microbiology. 2008; 62 :19-33. DOI: 10.1146/annurev.micro.61.080706.093305 - 28.
Klepzig K, Adams A, Handelsman J, Raffa K. Symbioses: A key driver of insect physiological processes, ecological interactions. Evolutionary Diversification, and Impacts on Humans*. 2009; 38 :67-77. DOI: 10.1603/022.038.0109 - 29.
Stukenbrock E, Croll D. The evolving fungal genome. Fungal Biology Reviews. 2014; 28 :1-12. DOI: 10.1016/J.FBR.2014.02.001 - 30.
Lovero K, Treseder K. Trade-offs between growth rate and other fungal traits. Frontiers in Forests and Global Change. 2021; 4 :756650. DOI: 10.3389/ffgc.2021.756650 - 31.
Woodhams D, Alford R, Briggs C, Johnson M, Rollins-Smith L. Life-history trade-offs influence disease in changing climates: Strategies of an amphibian pathogen. Ecology. 2008; 89 (6):1627-1639. DOI: 10.1890/06-1842.1 - 32.
Ademe M. Immunomodulation for the treatment of fungal infections: Opportunities and challenges. Frontiers in Cellular and Infection Microbiology. 2020; 10 :469. DOI: 10.3389/fcimb.2020.00469 - 33.
Armstrong-James D, Brown G, Netea M, Zelante T, Gresnigt M, Veerdonk F, et al. Immunotherapeutic approaches to treatment of fungal diseases. The Lancet. Infectious diseases. 2017; 17 (12):e393-e402. DOI: 10.1016/S1473-3099(17)30442-5 - 34.
Williams T, Harvey S, Armstrong- James D. Immunotherapeutic approaches for fungal infections. Current Opinion in Microbiology. 2020; 58 :130-137. DOI: 10.1016/j.mib.2020.09.007 - 35.
Gustafson E, Bakotic W, Bennett L, Page L, McCarthy L. DNA-based detection for onychomycosis correlates better to histopathology than does fungal culture. Dermatology Online Journal. 2019; 25 :7. DOI: 10.5070/D3257044800 - 36.
Nie X, Li B, Wang S. Epigenetic and posttranslational modifications in regulating the biology of aspergillus species. Advances in Applied Microbiology. 2018; 105 :191-226. DOI: 10.1016/bs.aambs.2018.05.004 - 37.
Procop G. Molecular diagnostics for the detection and characterization of microbial pathogens. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2007; 45 (Suppl. 2):S99-S111. DOI: 10.1086/519259 - 38.
Filler S, Sheppard D. Fungal invasion of normally non-phagocytic host cells. PLoS Pathogens. 2006; 2 (2):e129. DOI: 10.1371/journal.ppat.0020129 - 39.
Sonnex C. Toll-like receptors and genital tract infection. International Journal of STD & AIDS. 2010; 21 :153-157. DOI: 10.1258/ijsa.2009.009525 - 40.
Barbosa E, Gonçalves A, Guerra M, Cruz C. A systematic review on resource allocation in public health. European Journal of Public Health. 2020; 30 :v1018-v1019. DOI: 10.1093/eurpub/ckaa166.1309 - 41.
Giraud T, Refrégier G, Mickael Le G, et al. Speciation in fungi. Fungal Genetics and Biology: FG & B. 2008; 45 (6):791-802. DOI: 10.1016/j.fgb.2008.02.001 - 42.
Meredith DMJ, Irene F, Gadelha C, et al. Discovery of novel intermediate forms redefines the fungal tree of life. Nature. 2011; 474 :200-203. DOI: 10.1038/nature09984 - 43.
Alshehri B, Palanisamy M. Evaluation of molecular identification of Aspergillus species causing fungal keratitis. Saudi Journal of Biological Sciences. 2019; 27 :751-756. DOI: 10.1016/j.sjbs.2019.12.030 - 44.
Parismita B, Barua P, Pranjal Jyoti D, et al. Onychomycosis associated with superficial skin infection due to Aspergillus sydowii in an immunocompromised patient. Mycopathologia. 2019; 184 :683-689. DOI: 10.1007/s11046-019-00383-2 - 45.
Themistoklis KK, Fuchs B, Jeffrey JC, et al. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2012; 54 (9):1322-1331. DOI: 10.1093/cid/cis132 - 46.
McCarthy M, Walsh T. PCR methodology and applications for the detection of human fungal pathogens. Expert Review of Molecular Diagnostics. 2016; 16 :1025-1036. DOI: 10.1080/14737159.2016.1219253 - 47.
Alexandra NM, Jeffery U, Zachary GS, et al. Diagnostic accuracy of a direct panfungal polymerase chain reaction assay performed on stained cytology slides. Veterinary Pathology. 2021; 58 :542-548. DOI: 10.1177/0300985821991562 - 48.
Criven J, Tenforde M, Levitz S, et al. Modulating host immune responses to fight invasive fungal infections. Current Opinion in Microbiology. 2017; 40 :95-103. DOI: 10.1016/j.mib.2017.10.018 - 49.
Fisher R, Bridget G, Helaine S. Persistent bacterial infections and persister cells. Nature Reviews Microbiology. 2017; 15 :453-464. DOI: 10.1038/nrmicro.2017.42 - 50.
Sipsas N, Kontoyiannis D. Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2006; 42 (11):1584-1591. DOI: 10.1086/503844 - 51.
Georgopapadakou N, Jan ST. The fungal cell wall as a drug target. Trends in Microbiology. 1995; 3 (3):98-104. DOI: 10.1016/S0966-842X(00)88890-3 - 52.
Kung V, Chernock R, Burnham C. Diagnostic accuracy of fungal identification in histopathology and cytopathology specimens. European Journal of Clinical Microbiology & Infectious Diseases. 2017; 37 :157-165. DOI: 10.1007/s10096-017-3116-3 - 53.
Kanafani Z, Perfect J. Resistance to antifungal agents: Mechanisms and clinical impact. Clinical Infectious Diseases. 2008; 46 :120-128. DOI: 10.1086/524071 - 54.
Bossche HV, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi. Trends in Microbiology. 1994; 2 (10):393-400. DOI: 10.1016/0966-842X(94)90618-1